[HTML][HTML] Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PloS one, 2016 - journals.plos.org
Background Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …
[PDF][PDF] Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
N Abdel-Wahab, M Shah… - PLoS ONE, 2016 - pdfs.semanticscholar.org
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A
Systematic Review of Case Reports Page 1 RESEARCH ARTICLE Adverse Events Associated …
Systematic Review of Case Reports Page 1 RESEARCH ARTICLE Adverse Events Associated …
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PLoS ONE, 2016 - go.gale.com
Background Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …
[引用][C] Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PLOS ONE, 2016 - cir.nii.ac.jp
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A
Systematic Review of Case Reports | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Systematic Review of Case Reports | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports.
N Abdel-Wahab, M Shah, ME Suarez-Almazor - Plos one, 2016 - europepmc.org
Background Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …
[引用][C] Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PLoS ONE, 2016 - ui.adsabs.harvard.edu
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A
Systematic Review of Case Reports - NASA/ADS Now on home page ads icon ads Enable full …
Systematic Review of Case Reports - NASA/ADS Now on home page ads icon ads Enable full …
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PLOS ONE, 2016 - ideas.repec.org
Background: Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports.
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PLoS ONE, 2016 - search.ebscohost.com
Background: Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …
Adverse events associated with immune checkpoint blockade in patients with cancer: A systematic review of case reports
N Abdel-Wahab, M Shah… - PloS one, 2016 - mdanderson.elsevierpure.com
Background Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PloS one, 2016 - pubmed.ncbi.nlm.nih.gov
Background Three checkpoint inhibitor drugs have been approved by the US Food and
Drug Administration for use in specific types of cancers. While the results are promising …
Drug Administration for use in specific types of cancers. While the results are promising …